The Medicines and Healthcare products Regulatory Agency (MHRA) has released a consultation on the potential reclassification of codeine linctus to a prescription-only medicine.
Our Regulatory, Quality and Pharmacovigilance subject matter experts here at JensonR+ can help reset your Sat Nav and ensure clarity of route and navigate the potholes and high-cost toll roads to keep you on track.
If you are tinkering under the bonnet and feel you require the diagnostics approach a specialist consultancy, such as JensonR+ can help. We aid in the strategy; the maintenance by fixing faults before they become running issues and can also give you a regulatory MOT.
If you are a company or an individual wishing to promote a medicine by way of advertising, you need to ensure you know the rules of the road before you embark on this as there are many important factors to consider.
There are two words which often sit together when organisations discuss brand plans and company objectives for these, “Strategy and Tactics”. Have you however paused to consider them in full and to understand how they can guide you and what those differences are?
The page is still nearly blank for 2022 and now is the time if you’ve not already done so to sit back and reflect on what went well in 2021 and changes that need to be made for 2022. Are you going to repeat those “learnings” from 2021 or make a step change and see things possibly in a different light?